- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02174796
Hemodynamic Repercussions of the Correction (Surgical and Non Surgical) of Pectus Excavatum-type Thoracic Deformities (PECTUS)
July 18, 2017 updated by: Centre Jean Perrin
this non-randomized prospective study of 2 longitudinal cohorts (surgical treatment group or orthopedic treatment group), will evaluate the hemodynamic repercussions of the correction (surgical and non surgical) of pectus excavatum-type thoracic deformities by measuring the cardiac output difference before and after intervention, measured by transthoracic impedancemetry, during an exercise stress test
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Clermont-Ferrand, France, 63011
- Centre Jean Perrin
-
Clermont-Ferrand, France, 63000
- CHU de Clermont-Ferrand, Médecine du sport et d'explorations fonctionnelles
-
Clermont-Ferrand, France, 63011
- CHU G Montpied, Service de Cardiologie et Maladies Vasculaires
-
Saint-Priest en Jarez, France, 42055
- CHU de St Etienne, Hôpital Nord, Chirurgie thoracique
-
St Etienne, France, 42100
- CHU de Saint-Étienne, Hôpital Bellevue, Médecine du Sport et explorations fonctionnelles
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 40 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients seeking treatment of a pectus excavatum
- Haller index > 3.2
- Desire for treatment
- age between 15 and 40 years old
Exclusion Criteria:
- Cognitive impairment
- Pregnancy
- Contraindication to exercise stress test or general anesthesia
- Coagulation disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Surgical treatment group
patients who chose to undergo a surgical correction (Ravitch or Nuss type intervention). intervention: surgical correction (Ravitch or Nuss type intervention). |
patients who chose to undergo a surgical correction (Ravitch or Nuss type intervention).
|
EXPERIMENTAL: Orthopedic treatment group
patients who chose an orthopedic treatment by vacuum bell.
intervention : orthopedic treatment by vacuum bell.
|
orthopedic treatment by vacuum bell.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac output difference before and after intervention,during an exercise stress test
Time Frame: 4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Cardiac output measured by transthoracic impedancemetry, during an exercise stress test
|
4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rest lung function tests
Time Frame: 4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
|
Exercise functional capacity
Time Frame: 4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
|
Exercise cardiac output
Time Frame: 4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Exercise cardiac output (measured by transthoracic echocardiography)
|
4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Quality of life
Time Frame: 4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Quality of life SF36
|
4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Mean energy expenditure
Time Frame: 4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Mean energy expenditure will be evaluated by metabolic and physical activity monitor "armband" during 3 days (Kcal/min)
|
4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Evaluation of postoperative neuropathic pain
Time Frame: 4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
4 months before treatment (initial evaluation E1) just before treatment (intermediate evaluation E2) and 4 months after surgical treatment (TC) or orthopedic treatment (TO) of the deformation (final evaluation E3)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marc Filaire, Pr, Centre Jean Perrin, Service de Chirurgie Thoracique
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 5, 2014
Primary Completion (ACTUAL)
February 1, 2017
Study Completion (ACTUAL)
July 1, 2017
Study Registration Dates
First Submitted
April 23, 2014
First Submitted That Met QC Criteria
June 24, 2014
First Posted (ESTIMATE)
June 26, 2014
Study Record Updates
Last Update Posted (ACTUAL)
July 19, 2017
Last Update Submitted That Met QC Criteria
July 18, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-A01811-44
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pectus Excavatum
-
Galderma R&DPharma Consulting Group ABCompletedPectus Excavatum DeformityFrance, Sweden
-
Children's Health System, Inc.Walter Lorenz Surgical CorporationUnknownRepair of Pectus ExcavatumUnited States, Canada
-
Acibadem UniversityUnknownPhysical Disability | Psychosocial Impairment | Pectus DeformityTurkey
-
Zuyderland Medisch CentrumAtriCure, Inc.RecruitingFunnel Chest | Pectus ExcavatumNetherlands
-
Zuyderland Medisch CentrumUnknownPectus ExcavatumNetherlands
-
Baylor College of MedicineTerminatedPectus ExcavatumUnited States
-
Medical University InnsbruckCompletedPectus Excavatum | Pectus CarinatumAustria
-
Johns Hopkins All Children's HospitalCompletedPectus ExcavatumUnited States
-
Zuyderland Medisch CentrumUnknown
-
Zuyderland Medisch CentrumUnknownPectus ExcavatumNetherlands
Clinical Trials on surgical treatment
-
HealthCore-NERIUniversity of California, San Diego; University of Maryland; University of Alabama... and other collaboratorsTerminated
-
Peking University Third HospitalRecruitingOsteoarthritis, Knee | Anterior Cruciate Ligament RuptureChina
-
Uppsala UniversityCompletedSpinal Fractures
-
Kolding SygehusOdense University Hospital; Karolinska University Hospital; Zealand University... and other collaboratorsRecruitingFracture Humerus of ShaftSweden, Finland, Denmark, Norway
-
Sahlgrenska University Hospital, SwedenActive, not recruitingRupture | Ultrasonography | Acute Disease | Athletic Injuries | Achilles Tendon RuptureSweden
-
Medtronic Neurovascular Clinical AffairsRecruiting
-
AO Innovation Translation CenterRecruitingLong Bone FracturesUnited States, Canada, Australia, Ghana, Chile, China, Germany, India, Pakistan, Venezuela, Spain, Croatia, Greece
-
AO Clinical Investigation and Publishing DocumentationActive, not recruitingFemoral Shaft FractureUnited States, Canada, Switzerland, Germany, Austria
-
Hospital Severo OchoaCompleted
-
University of CologneCompletedOutcome, Fatal | Vertebral Osteomyelitis | Spondylodiscitis